The ethical landscape of medical research is shifting decisively as 2026 begins, with a record number of pharmaceutical companies abandoning traditional animal models in favor of bioprinted human tissue chips. New 2026 mandates from the European Parliament have officially recognized "micro-physiological systems" as a superior alternative for early-stage toxicity screening. This transition is...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek